Literature DB >> 33469161

A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.

Pengpeng Zhu1, Fang He2, Yixuan Hou3, Gang Tu4, Qiao Li1, Ting Jin1, Huan Zeng1, Yilu Qin1, Xueying Wan1, Yina Qiao1, Yuxiang Qiu1, Yong Teng5, Manran Liu6.   

Abstract

The hostile hypoxic microenvironment takes primary responsibility for the rapid expansion of breast cancer tumors. However, the underlying mechanism is not fully understood. Here, using RNA sequencing (RNA-seq) analysis, we identified a hypoxia-induced long noncoding RNA (lncRNA) KB-1980E6.3, which is aberrantly upregulated in clinical breast cancer tissues and closely correlated with poor prognosis of breast cancer patients. The enhanced lncRNA KB-1980E6.3 facilitates breast cancer stem cells (BCSCs) self-renewal and tumorigenesis under hypoxic microenvironment both in vitro and in vivo. Mechanistically, lncRNA KB-1980E6.3 recruited insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) to form a lncRNA KB-1980E6.3/IGF2BP1/c-Myc signaling axis that retained the stability of c-Myc mRNA through increasing binding of IGF2BP1 with m6A-modified c-Myc coding region instability determinant (CRD) mRNA. In conclusion, we confirm that lncRNA KB-1980E6.3 maintains the stemness of BCSCs through lncRNA KB-1980E6.3/IGF2BP1/c-Myc axis and suggest that disrupting this axis might provide a new therapeutic target for refractory hypoxic tumors.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33469161      PMCID: PMC7932928          DOI: 10.1038/s41388-020-01638-9

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  65 in total

Review 1.  Hallmarks of pluripotency.

Authors:  Alejandro De Los Angeles; Francesco Ferrari; Ruibin Xi; Yuko Fujiwara; Nissim Benvenisty; Hongkui Deng; Konrad Hochedlinger; Rudolf Jaenisch; Soohyun Lee; Harry G Leitch; M William Lensch; Ernesto Lujan; Duanqing Pei; Janet Rossant; Marius Wernig; Peter J Park; George Q Daley
Journal:  Nature       Date:  2015-09-24       Impact factor: 49.962

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.

Authors:  Yan Chen; Bo Zhang; Lei Bao; Lai Jin; Mingming Yang; Yan Peng; Ashwani Kumar; Jennifer E Wang; Chenliang Wang; Xuan Zou; Chao Xing; Yingfei Wang; Weibo Luo
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 4.  Patterns of Genomic Instability in Breast Cancer.

Authors:  Murugan Kalimutho; Katia Nones; Sriganesh Srihari; Pascal H G Duijf; Nicola Waddell; Kum Kum Khanna
Journal:  Trends Pharmacol Sci       Date:  2019-02-06       Impact factor: 14.819

5.  The Role of APAL/ST8SIA6-AS1 lncRNA in PLK1 Activation and Mitotic Catastrophe of Tumor Cells.

Authors:  Man-Li Luo; Jingjing Li; Liping Shen; Junjun Chu; Qiannan Guo; Guorun Liang; Wei Wu; Jianing Chen; Rufu Chen; Erwei Song
Journal:  J Natl Cancer Inst       Date:  2020-04-01       Impact factor: 13.506

6.  Molecular landmarks of tumor hypoxia across cancer types.

Authors:  Vinayak Bhandari; Christianne Hoey; Lydia Y Liu; Emilie Lalonde; Jessica Ray; Julie Livingstone; Robert Lesurf; Yu-Jia Shiah; Tina Vujcic; Xiaoyong Huang; Shadrielle M G Espiritu; Lawrence E Heisler; Fouad Yousif; Vincent Huang; Takafumi N Yamaguchi; Cindy Q Yao; Veronica Y Sabelnykova; Michael Fraser; Melvin L K Chua; Theodorus van der Kwast; Stanley K Liu; Paul C Boutros; Robert G Bristow
Journal:  Nat Genet       Date:  2019-01-14       Impact factor: 38.330

Review 7.  Cancer stem cells revisited.

Authors:  Eduard Batlle; Hans Clevers
Journal:  Nat Med       Date:  2017-10-06       Impact factor: 53.440

Review 8.  Intra-tumor heterogeneity from a cancer stem cell perspective.

Authors:  Pramudita R Prasetyanti; Jan Paul Medema
Journal:  Mol Cancer       Date:  2017-02-16       Impact factor: 27.401

9.  SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation.

Authors:  Peiyuan Zhang; Yingjie Liu; Cheng Lian; Xuan Cao; Yuan Wang; Xiaoxun Li; Min Cong; Pu Tian; Xue Zhang; Gang Wei; Tong Liu; Guohong Hu
Journal:  Nat Commun       Date:  2020-05-19       Impact factor: 14.919

Review 10.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment.

Authors:  Xinming Jing; Fengming Yang; Chuchu Shao; Ke Wei; Mengyan Xie; Hua Shen; Yongqian Shu
Journal:  Mol Cancer       Date:  2019-11-11       Impact factor: 27.401

View more
  38 in total

Review 1.  RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.

Authors:  Subhadra Kumari; Santosh Kumar; Srinivasan Muthuswamy
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-07       Impact factor: 4.553

2.  LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.

Authors:  Huizhe Wu; Xiangyu Ding; Xiaoyun Hu; Qing Zhao; Qiuchen Chen; Tong Sun; Yalun Li; Hao Guo; Meng Li; Ziming Gao; Weifan Yao; Lin Zhao; Kai Li; Minjie Wei
Journal:  Oncogene       Date:  2022-02-16       Impact factor: 9.867

Review 3.  Crosstalk between m6A regulators and mRNA during cancer progression.

Authors:  Xiaodong Niu; Yuan Yang; Yanming Ren; Shengtao Zhou; Qing Mao; Yuan Wang
Journal:  Oncogene       Date:  2022-08-25       Impact factor: 8.756

4.  DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.

Authors:  Chunfeng Ren; Hongbin Han; Jingjing Pan; Qian Chang; Wanhai Wang; Xiaobing Guo; Jing Bian
Journal:  Mamm Genome       Date:  2022-10-12       Impact factor: 3.224

Review 5.  Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy.

Authors:  Antonella Barone; Nicola d'Avanzo; Maria Chiara Cristiano; Donatella Paolino; Massimo Fresta
Journal:  Biomedicines       Date:  2022-05-27

Review 6.  The Key Role of RNA Modification in Breast Cancer.

Authors:  Yang Liu; Tong Zhu; Yi Jiang; Jiawen Bu; Xudong Zhu; Xi Gu
Journal:  Front Cell Dev Biol       Date:  2022-06-01

Review 7.  Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.

Authors:  Fusheng Zhang; Haiyang Liu; Meiqi Duan; Guang Wang; Zhenghou Zhang; Yutian Wang; Yiping Qian; Zhi Yang; Xiaofeng Jiang
Journal:  J Hematol Oncol       Date:  2022-07-06       Impact factor: 23.168

8.  LINC00173 promotes Wilms' tumor progression through MGAT1-mediated MUC3A N-glycosylation.

Authors:  Qingliang Zhu; Deming Zhan; Yongguo Yang; Yankun Chong; Haoliang Xue; Peng Zhu
Journal:  Cell Cycle       Date:  2022-06-14       Impact factor: 5.173

Review 9.  The emerging role of RNA N6-methyladenosine methylation in breast cancer.

Authors:  Fangchao Zheng; Feng Du; Jiuda Zhao; Xue Wang; Yiran Si; Peng Jin; Haili Qian; Binghe Xu; Peng Yuan
Journal:  Biomark Res       Date:  2021-05-27

Review 10.  The Hypoxia-Long Noncoding RNA Interaction in Solid Cancers.

Authors:  Seung Wan Son; Ba Da Yun; Mun Gyu Song; Jin Kyeong Lee; Soo Young Choi; Hyo Jeong Kuh; Jong Kook Park
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.